Feng Ye

机构：Pfizer (United States) · ORCID：0000-0002-6749-0417

发表论文 52 篇 · 总被引 994 次 · h-index 17

代表论文

• MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer (2020 · Academic Radiology · 被引 64)
• Long‐term efficacy and safety of gonadotropin‐releasing hormone analog treatment in children with idiopathic central precocious puberty: A systematic review and meta‐analysis (2021 · Clinical Endocrinology · 被引 54)
• High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target (2021 · PLoS ONE · 被引 32)
• Isolation, structural and bioactivities of polysaccharides from Anoectochilus roxburghii (Wall.) Lindl.: A review (2023 · International Journal of Biological Macromolecules · 被引 30)
• Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression (2022 · Journal of Pharmacology and Experimental Therapeutics · 被引 23)
• Predicting perineural invasion using histogram analysis of zoomed EPI diffusion-weighted imaging in rectal cancer (2022 · Abdominal Radiology · 被引 11)